Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138735 · ClinicalTrials.gov registry record · Phase 4
Epiduo Pediatric Acne Study
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 285
- Enrollment target
NCT01138735: Completed Phase 4 study, sponsored by Galderma R&D.
NCT01138735 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 285 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01138735, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 285 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once daily for up to 12 weeks in subjects 9 to 11 years of age with acne vulgaris.
Primary Outcome
Percentage of subjects rated Clear or Almost Clear with at least 2 grades reduction from Baseline on the Investigator's Global Assessment (IGA)
Interventions
- DRUG Topical Gel Vehicle
- DRUG adapalene/benzoyl peroxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
What the finished NCT01138735 record still lists
NCT01138735 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 2 interventions - of which Topical Gel Vehicle is the first listed.
NCT01138735 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01138735 about?
NCT01138735 is a clinical study titled "Epiduo Pediatric Acne Study". The purpose of this study is to evaluate the safety and efficacy of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once daily for up to 12 weeks in subjects 9 to 11 years of age with acne vulgaris.
What is the current status of trial NCT01138735?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 285 participants. The study started on 2010-06. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01138735?
The interventions under investigation include: Topical Gel Vehicle (DRUG), adapalene/benzoyl peroxide (DRUG).
Who is sponsoring clinical trial NCT01138735?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01138735's enrollment target sits among peer trials
285 302nd of 2000 higher than 1,699 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03412877 · 285 participants · Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- NCT04537936 · 285 participants · NA
Psychotherapy Intervention for Latinos With Adv Cancer
- NCT04965675 · 285 participants · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- NCT05320835 · 285 participants · NA
A Setting Focus Overdose Prevention Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia